Emerald Mutual Fund Advisers Trust Biomarin Pharmaceutical Inc Transaction History

Emerald Mutual Fund Advisers Trust

  • $1.77 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024
BUY
$76.22 - $98.51 $44,360 - $57,332
582 Added 61.39%
1,530 $147,000
Q3 2023

Oct 26, 2023
SELL
$85.07 - $94.48 $1,786 - $1,984
-21 Reduced 2.17%
948 $83,000
Q2 2023

Aug 10, 2023
BUY
$86.68 - $100.3 $83,992 - $97,190
969 New
969 $83,000
Q4 2022

Feb 03, 2023
BUY
$80.93 - $108.63 $84,895 - $113,952
1,049 New
1,049 $108,000

Others Institutions Holding BMRN

# of Institutions
635
Shares Held
178M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $11.8B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Emerald Mutual Fund Advisers Trust Portfolio

Follow Emerald Mutual Fund Advisers Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email